-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Protagonist Therapeutics, Raises Price Target to $137

Benzinga·05/06/2026 14:36:01
Listen to the news
Citizens analyst Jonathan Wolleben maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Market Outperform and raises the price target from $120 to $137.